---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-066931"
form_type: "8-K"
ticker: "TEM"
cik: "0001717115"
company_name: "Tempus AI, Inc."
filed_at: "2026-02-24T23:59:59+00:00"
generated_at: "2026-05-16T00:50:39.409034+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Tempus AI Q4 revenue $367.2M (+83% YoY); guides FY26 revenue ~$1.59B, adj. EBITDA ~$65M

## Summary
- Q4 revenue $367.2M (+83% YoY, 33.5% organic); Diagnostics $266.9M (+121.6%) with Oncology volume +29%, Hereditary +23%.
- Data and Apps revenue $100.4M (+25.1%); Insights ex-warrant grew 69.5%; total remaining contract value >$1.1B, NRR 126%.
- Q4 net loss $54.2M vs $13.0M loss YoY; Adj. EBITDA improved to $12.9M from ($7.8M) prior year.
- FY2025 revenue $1.3B (+83.4%); net loss $245.0M; Adj. EBITDA ($7.4M) vs ($104.7M) prior year.
- Cash and marketable securities $759.7M; FY2026 guidance: revenue ~$1.59B, Adj. EBITDA ~$65M.

## SEC filing metadata
- accession: 0001193125-26-066931
- form_type: 8-K
- ticker: TEM
- cik: 0001717115
- company_name: Tempus AI, Inc.
- filed_at: 2026-02-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1717115/000119312526066931/0001193125-26-066931-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1717115/000119312526066931/tem-20260224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-066931
- JSON: https://secwatch.observer/filing/0001193125-26-066931.json
- Plain text: https://secwatch.observer/filing/0001193125-26-066931.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.